Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study

Authors :: L.M.G. Meems
V. Artola Arita
M. Velt
E.A.M.P. Dudink
H.J.G.M. Crijns
I.C. Van Gelder
M. Rienstra
Source :: International Journal of Cardiology: Heart & Vasculature, Vol 39, Iss , Pp 100987- (2022)
Publication Year :: 2022
Publisher :: Elsevier, 2022.
Abstract: Atrial fibrillation (AF) is a progressive disease, and early recognition and management may reflect an important strategy to reduce its disease burden. In this study, we evaluated plasma levels of three biomarkers - N-terminal pro-brain natriuretic peptide (NTproBNP), Troponin-T, and growth differentiation factor-15 (GDF-15) - in patients with paroxysmal AF (pAF) (≤7 days of continuous AF, n = 323) and persistent AF ((AF duration > 7 days and

Subjects :: Atrial fibrillation
Biomarkers
NTproBNP
Growth-differentiation factor 15
Troponin T
Diseases of the circulatory (Cardiovascular) system
RC666-701

Full Text Access

Tools